Plain-English translation of NCT05903742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows people who have hepatitis delta — a serious liver infection that happens when someone has both hepatitis B and hepatitis D viruses. Researchers want to collect information about how the disease develops over time and how well treatments work, so they can help future patients.
Hepatitis delta is rare, so doctors don't have enough experience treating it and managing it well. This study will gather real-world information to help doctors understand the disease better and provide better care for patients.
You likely qualify if…
You likely don't qualify if…
You will be part of a 5-year study where researchers follow your health during your regular doctor visits. You'll provide small blood samples (about 2 teaspoons) when you already have routine blood work done, and you'll fill out two short quality-of-life surveys each year. There are no special medications or procedures — just tracking what's happening with your liver health over time.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Netherlands
Enrollment target
~80 participants
Started
January 2024
Primary completion
September 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lesley Patmore, MD
Erasmus Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.